Company

BioNTech

Public · Nasdaq: BNTXpharmaceutical industryGermany

BioNTech führt Sie durch die spannende Welt der Immuntherapien. Hier finden Sie Informationen zur Grundlagenforschung und zu neuartigen Behandlungsmöglichkeiten.

BioNTech is a publicly traded company operating in the pharmaceutical industry sector, based in Germany. It trades on the Nasdaq under the ticker BNTX. Leadership tracked by CEOInsider includes Uğur Şahin (CEO).

biontech.de ↗LinkedIn ↗

Leadership

Current

Uğur Şahin

CEO

Recent developments

AI summary of recent coverage

Recent coverage has focused on BioNTech CEO Ugur Sahin's regular share sales executed under a prearranged trading plan throughout September and October, with the executive maintaining a substantial stake in the company despite these transactions. Additionally, coverage has highlighted BioNTech's co-founders announcing the launch of a new pharmaceutical company called Arife, expected to begin operations by the end of 2026.

Summarized from the headlines in the sidebar; see each source for the full story.